Dömling Alexander PhD.

Journals

CHEN, S., M. CAL, Q. MONDILE, R. OERLEMANS, M. MUKIM, A. DÖMLING, O. BISHOP, P. MASER, M. GROVES
Repurposing of Inhibitors of Plasmodial Aspartate Transcarbamoylase Toward Trypanosoma Cruzi. ChemMedChem. 2026, 21(6), e202500817, ISSN: 1860-7179, PMID: 41886248,  PDF.
RAMMAH, M., A. REYES ROMERO, N. HALABI, S. ABUAQUEL, A. GUENNOUN, A. DÖMLING, J. SHAN, L. CHOUCHANE
A small‑molecule HDAC/PDE modulator activates human adipocyte UCP1 and resolves inflammatory signaling. Journal of Translational Medicine. 2026, ISSN: 1479-5876, PMID: 41787480,  PDF.
KHOSRAVIFARD, S., S. HOSSEINKHANI, N. BAKHTIARY, M. PEYVANDI, A. DÖMLING
Disruption of NLRP3 inflammasome assembly via ligand-induced remodeling of pyrin domain interfaces. Scientific Reports. 2026, ISSN: 2045-2322, PMID: 41513945,  PDF.

Postdoctoral mentorship

Reyes Romero Atilio Ph.D.

Accellerated Drug Discovery and Screening

Doctoral mentorship

Guan Zhirui

Discovery and development of novel macrocycles via Multicomponent reactions

Status: Ongoing from 2023.
Capriello Imma

Molecular targets for innovative pharmaceutics

Status: Ongoing from 2023.
Fusco Riccardo

Plasmonic Nanomaterials in Cancer Theranostics

Status: Ongoing from 2023.